Pingyuan Wang
Impact in
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Mitochondrial Function and Pathology
- Ubiquitin and proteasome pathways
- Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Mitochondrial Function and Pathology 13
- Receptor Mechanisms and Signaling 10
- Protein Kinase Regulation and GTPase Signaling 7
- Protein Degradation and Inhibitors 6
-
- Cancer, Hypoxia, and Metabolism 13
- Co-authors
- Paul M. Hwang (29 shared papers)Jia Zhou (34 shared papers)Richard G.W. Anderson (4 shared papers)Jian Weng (2 shared papers)Zhiqing Liu (25 shared papers)Haiying Chen (19 shared papers)Ju‐Gyeong Kang (14 shared papers)Robert S. Munford (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (14 papers)Journal of Biological Chemistry (7 papers)European Journal of Medicinal Chemistry (6 papers)Proceedings of the National Academy of Sciences (4 papers)The Journal of Immunology (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Pingyuan Wang
101 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 141
- Molecular Biology 1.9k
- Oncology 673
- Cancer Research 363
- Hematology 243
- Geriatrics and Gerontology 55
Countries citing papers authored by Pingyuan Wang
This map shows the geographic impact of Pingyuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingyuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingyuan Wang more than expected).
Fields of papers citing papers by Pingyuan Wang
This network shows the impact of papers produced by Pingyuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingyuan Wang. The network helps show where Pingyuan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingyuan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 269 | |
| 2 | 2005 | 254 | |
| 3 | 2016 | 201 | |
| 4 | 2009 | 173 | |
| 5 | 2010 | 123 | |
| 6 | 2013 | 106 | |
| 7 | 2018 | 84 | |
| 8 | 1998 | 83 | |
| 9 | 2020 | 83 | |
| 10 | 1998 | 82 | |
| 11 | 2019 | 72 | |
| 12 | 2020 | 71 | |
| 13 | 2013 | 67 | |
| 14 | 2019 | 65 | |
| 15 | 2009 | 63 | |
| 16 | 2014 | 60 | |
| 17 | 2018 | 55 | |
| 18 | 2011 | 51 | |
| 19 | 2016 | 50 | |
| 20 | 2022 | 48 |
About Pingyuan Wang
Pingyuan Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Physiology and Cellular and Molecular Neuroscience, having authored 108 papers that have together received 3.4k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (13 papers), Cancer, Hypoxia, and Metabolism (13 papers), Receptor Mechanisms and Signaling (10 papers), Cancer-related Molecular Pathways (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Adipose Tissue and Metabolism (7 papers), Protein Degradation and Inhibitors (6 papers) and PARP inhibition in cancer therapy (6 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Oncology (673 citations), Cancer Research (363 citations), Hematology (243 citations) and Geriatrics and Gerontology (55 citations). Pingyuan Wang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Paul M. Hwang, Jia Zhou, Richard G.W. Anderson, Jian Weng, Zhiqing Liu, Haiying Chen, Ju‐Gyeong Kang, Robert S. Munford, Allan R. Brasier and Bing Tian. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, European Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.